Weight Loss Injections
- All
- News
-
Ozempic Too Costly? 7 Cheaper And Clinically Approved Alternatives Available In India
Ozempic has hit the Indian market and will be available at Rs 2,200 per week. But did you know that there are alternatives which can also aid in weight loss?
-
Can Non-Diabetics Take Ozempic For Weight Loss? Doctor Answers
Ozempic is the brand name for a medication called semaglutide, which is primarily used to manage type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists
-
Ozempic Injection Price In India: How Affordable Is It For Diabetes And Weight Loss?
Ozempic, a once-weekly semaglutide injection for type-2 diabetes, has debuted in India with pricing starting at roughly Rs 2,200 per week.
-
Ozempic Launched In India: Doctors Welcome New Diabetes Drug, Warn Against Misuse For Weight Loss
Doctors highlight that the drug should be administered along with a healthy diet and regular exercise for management of type 2 diabetes, and not just as cosmetic procedure for weight loss.
-
Diabetes, Weight Loss Drug Ozempic Launched In India: See Dosage, Price And More
Novo Nordisk on Friday launched its blockbuster weight-loss drug Ozempic in India, beginning at Rs 8,800 a month or four weeks.
-
Chinese Woman Vomits Blood, Suffers Severe Reaction After Taking Weight-Loss Injections
The woman's condition deteriorated, and she vomited blood, leading to hospitalisation.
-
Chinese Woman Pays Rs 11,000 For 3 Weight Loss Injections, Ends Up Vomiting Blood And With No Pulse
The woman lost 5 Kg in four days, but suffered from nausea, loss of appetite, burnt stomach lining, and a damaged digestive tract
-
Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India
Emcure Pharma becomes the first Indian company to hold exclusive rights to distribute and commercialise Poviztra, a semaglutide injection 2.4 mg for weight loss, the statement said.
-
Twinkle Khanna Opens Up On Weight Loss Struggles During Perimenopause: "Should I Too Inject Myself?"
Twinkle Khanna shared she had been on every diet, but decided not to starve anymore
-
Ozempic Launched In India: 14 Facts About The Diabetes, Weight Loss Drug
Semaglutide (Ozempic), a once-weekly injectable already approved globally, has now been launched in India for type 2 diabetes.
-
Ozempic Cleared For Use In India: Pros, Cons And Prices
Ozempic is the trade name for semaglutide, a once-weekly injectable medicine that belongs to the class called GLP-1 receptor agonists. A higher-dose semaglutide better known as Wegovy is licensed for chronic weight management.
-
Lilly's Obesity Pill Will Have Far-Reaching Effect, Doctors Say
Oral versions of popular weight-loss shots are some of the next big things in the obesity market, which Bloomberg Intelligence estimates will reach $100 billion in annual sales by 2030.
-
Higher Doses Of Semaglutide Safe, Can Aid In Better Weight Loss For Obese Adults: Study
A study published in The Lancet Diabetes & Endocrinology journal, suggest that a higher dose of semaglutide offers a promising new option for people who have not achieved sufficient weight loss with existing treatments.
-
Serena Williams Reveals She Lost 14 kg Using Weight-Loss Medication: "I Feel Great"
According to Williams, the medication has not only helped her lose weight but also improved her overall health, with noticeable enhancements in her blood sugar levels.
-
Are Mounjaro Jabs Safe? Mass Rollout Of Weight Loss Drug To Start In UK
NHS to monitor the mass rollout that will see around 220,000 people with the "greatest need" receive the weight loss jabs.
-
Ozempic Too Costly? 7 Cheaper And Clinically Approved Alternatives Available In India
Ozempic has hit the Indian market and will be available at Rs 2,200 per week. But did you know that there are alternatives which can also aid in weight loss?
-
Can Non-Diabetics Take Ozempic For Weight Loss? Doctor Answers
Ozempic is the brand name for a medication called semaglutide, which is primarily used to manage type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists
-
Ozempic Injection Price In India: How Affordable Is It For Diabetes And Weight Loss?
Ozempic, a once-weekly semaglutide injection for type-2 diabetes, has debuted in India with pricing starting at roughly Rs 2,200 per week.
-
Ozempic Launched In India: Doctors Welcome New Diabetes Drug, Warn Against Misuse For Weight Loss
Doctors highlight that the drug should be administered along with a healthy diet and regular exercise for management of type 2 diabetes, and not just as cosmetic procedure for weight loss.
-
Diabetes, Weight Loss Drug Ozempic Launched In India: See Dosage, Price And More
Novo Nordisk on Friday launched its blockbuster weight-loss drug Ozempic in India, beginning at Rs 8,800 a month or four weeks.
-
Chinese Woman Vomits Blood, Suffers Severe Reaction After Taking Weight-Loss Injections
The woman's condition deteriorated, and she vomited blood, leading to hospitalisation.
-
Chinese Woman Pays Rs 11,000 For 3 Weight Loss Injections, Ends Up Vomiting Blood And With No Pulse
The woman lost 5 Kg in four days, but suffered from nausea, loss of appetite, burnt stomach lining, and a damaged digestive tract
-
Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India
Emcure Pharma becomes the first Indian company to hold exclusive rights to distribute and commercialise Poviztra, a semaglutide injection 2.4 mg for weight loss, the statement said.
-
Twinkle Khanna Opens Up On Weight Loss Struggles During Perimenopause: "Should I Too Inject Myself?"
Twinkle Khanna shared she had been on every diet, but decided not to starve anymore
-
Ozempic Launched In India: 14 Facts About The Diabetes, Weight Loss Drug
Semaglutide (Ozempic), a once-weekly injectable already approved globally, has now been launched in India for type 2 diabetes.
-
Ozempic Cleared For Use In India: Pros, Cons And Prices
Ozempic is the trade name for semaglutide, a once-weekly injectable medicine that belongs to the class called GLP-1 receptor agonists. A higher-dose semaglutide better known as Wegovy is licensed for chronic weight management.
-
Lilly's Obesity Pill Will Have Far-Reaching Effect, Doctors Say
Oral versions of popular weight-loss shots are some of the next big things in the obesity market, which Bloomberg Intelligence estimates will reach $100 billion in annual sales by 2030.
-
Higher Doses Of Semaglutide Safe, Can Aid In Better Weight Loss For Obese Adults: Study
A study published in The Lancet Diabetes & Endocrinology journal, suggest that a higher dose of semaglutide offers a promising new option for people who have not achieved sufficient weight loss with existing treatments.
-
Serena Williams Reveals She Lost 14 kg Using Weight-Loss Medication: "I Feel Great"
According to Williams, the medication has not only helped her lose weight but also improved her overall health, with noticeable enhancements in her blood sugar levels.
-
Are Mounjaro Jabs Safe? Mass Rollout Of Weight Loss Drug To Start In UK
NHS to monitor the mass rollout that will see around 220,000 people with the "greatest need" receive the weight loss jabs.
